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Abstract
Healthcare redesign, based on building collaborative capacity between academic and clinical partners, should
create a method to facilitate flow between the key elements of health service improvement. However, utilising the
skills and resources of an organisation outside of the health facility may not always have the desired effect.
Accountability and mutually respectful relationships are fundamental for collaborative, sustainable and successful
completion of clinical research projects. This paper provides an academic perspective of both the benefits of
academic involvement in facilitating healthcare redesign processes as well as the potential pitfalls of involving
external partner institutions in internal healthcare redesign projects.
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Plain English summary
Health service delivery improvement can be a compli-
cated task requiring much time and resources. Re-
designing a service that is problematic requires clinical
knowledge and skills in that area. However, this process
also requires knowledge and skills to be able to assess
what is not working, and why, and to develop solutions
to improve the services through a variety of ways. Often,
hospitals or other healthcare providers request assistance
from academic staff from universities to ensure that
these tasks are completed, and that minimal time is
taken from healthcare professionals and their patients.
Historically, relationships between university academics
and healthcare providers have faced several challenges.
This paper discusses the challenges, and benefits, from
the academics’ point of view.
Background
Across Australia and internationally, healthcare services
are faced with challenges associated with a rising demand
for medical care. The delivery of efficient, best-practice
care is increasingly becoming the result of the redesign of
healthcare services, a time-consuming and resource-rich
process. External facilitation of healthcare redesign initia-
tives provides a means of bringing together key stake-
holders to achieve the intended outcomes by committing
resources at many different levels. In Australia, healthcare
has traditionally partnered with academic institutions
through various roles, including education, recruitment
and community projects [1]. Collaborative healthcare re-
design has also been utilised globally to improve patient
care and deliver best practice health services [2–5].
Recent problems in variations in the quality of health-
care in Australia has led to a shift in the direction of
healthcare redesign rather than solving problems as
they occur. This method of quality improvement has
been highlighted by the number of Australian projects,
including the redesign of healthcare services at Flinders
Medical Centre in South Australia [6], where patient
flow was improved in the overcrowded emergency de-
partment. Additionally, the development of local post-
graduate, work-integrated courses specifically designed
to deliver healthcare redesign projects [7] have been de-
veloped. For example, the University of Tasmania deliv-
ered several health service redesign projects throughout
Tasmania to improve the patient healthcare journey, in-
cluding improving the efficiency of the surgical theatre
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[8] and the reduction of outpatient waitlists in the
north of the state [9].
Healthcare redesign is a phasic process often per-
formed as a single service or discipline in the interests of
time and resources within the healthcare system itself.
Financial restrictions often mean that extra staff are un-
able to be employed specifically to focus on redesign ini-
tiatives, potentially leading to conflicts in workload such
as prioritisation of tasks and time management. The em-
ployment of academic institutions to provide support
throughout healthcare redesign can create more capacity
for research and evidence-based service development as
well as providing extra resources for the healthcare facil-
ity to deliver improved health services. Academics not
only provide human resources to deliver the clinical ex-
pectations from healthcare redesign, they also offer pro-
fessional outputs such as ethical approval processes,
publication in reputable peer-reviewed health and med-
ical journals, and opportunities for further research and
funding to develop clinical practice. The committed re-
sources, including human and fiscal, are necessary tools
for sustaining partnerships [10] and will greatly improve
the prospect of success in healthcare service redesign.
What is healthcare redesign?
Healthcare redesign has been broadly defined as “think-
ing through from scratch the best process to achieve
speedy and effective care from a patient perspective, iden-
tifying where delays, unnecessary steps or potential for
error are built into the process, and then redesigning the
process to remove them and dramatically improve the
quality of care” [11]. As a strategy for implementing
quality improvements and initiatives and to deliver
evidence-based, best practice, patient-centred care, the
process of healthcare, or clinical, redesign is an import-
ant tool for healthcare reform. This process of improv-
ing the quality of current health services and systems
generally occurs in five main phases (outlined in Table 1),
as described previously [6].
Healthcare redesign follows the patient journey and
identifies areas most in need of change to deliver im-
proved healthcare services. Redesign strategies can be ap-
plied to any facet of healthcare and have been shown to
be successful in several quality improvement initiatives.
For example, Choe et al. [12] reported the success of a
clinical redesign methodology for diabetic patients, 69% of
whom were able to meet their blood pressure target fol-
lowing a new reminder and self-management system. The
Australian national maternity reform agenda utilised a
major clinical redesign to establish a midwifery group
practice at a tertiary referral hospital in Sydney [13]. This
redesign project included the introduction of caseload
midwifery care under randomised trial conditions to ul-
timately improve patient access to midwifery services.
The redesign process requires input from a range of
key stakeholders and information from a variety of
sources, brought together on a regular basis to initiate
and maintain system changes. One of the major steps,
and often a significant hurdle in the redesign process,
is the engagement of key stakeholders, which may in-
clude clinicians, leadership groups, other staff, and
consumers or patients. Visible involvement of senior
management or leadership groups is essential for driv-
ing any change process [14] and enabling a sense of
trust and commitment. Patients, carers, families and
other consumers also play a major role in defining
problems and developing solutions within healthcare
redesign. The inclusion of the consumer voice means
that patients’ needs are better met and their experi-
ence will be improved, which has been shown to lead
to improved patient outcomes [15, 16]. Another fre-
quently occurring issue is the high level of time in-
volved in assembling and maintaining the stakeholder
group, one of many redesign processes that requires a
dedicated role by one team member.
Healthcare redesign can be internally or externally
driven, and an appropriate expertise and skill mix is fun-
damental for the success or failure of implementation in
each of the project phases. This expertise includes not
only clinical but also administrative, research-focused and
patient-centred project skills. Leadership within redesign
processes requires expertise, credibility and experience to
Table 1 Overview of healthcare redesign phases [6]
Phase Overview
1 Mapping Detailed view of the existing processes,
includes role delineation, responsibilities
and what is happening as a patient moves
through a healthcare service
2 Diagnosis All the information from the mapping is
pulled together to determine where problems
exist and why; a step-by-step questioning
process opens up the current systems and
allows processes to be defined and issues
revealed
3 Solutions Involves more clinical input, although a research
component is necessary to ensure evidence-based
solutions; during this phase, the opinions of all
stakeholders is required to develop ways of
moving forward and of improving the current
systems as
diagnosed in the first phase of redesign
4 Implementation The most difficult step – implementing the novel
solutions previously identified; involves combining
project management skills with managing the
human dimension of change in a complex
healthcare system
5 Evaluation Following implementation of solutions, an
evaluation process must be put in place to
measure the redesign outcomes; this may be
patient outcomes, organisational outcomes or
other quality and safety outcomes
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understand the complexity of the clinical interface and the
academic requirements, without compromising the valid-
ity of the process.
Developing partnerships
There are a range of contributing levels within clinical
redesign. Any proposed redesign processes need to be
cognisant of individuals, organisations and systems [17]
that may be impacted and need to be addressed if part-
nerships are to become successful in obtaining and
maintaining project cohesion [18]. Human factors, such
as shared vision [19], readiness [20], leadership, assigned
workload [19], engagement and ‘buy-in’ [21], ritual or re-
sistance [22], contribute to the successful development
or failure of partnerships. Power inequity is a challenge
that needs to be acknowledged early in any team devel-
opment [18]. Sound communication is paramount to
promote compliance of implementation plans among
stakeholders [19]. Similarly, the influences of the human
and physical environment and equipment requirements
should not be underestimated. For example, at a systems
level, co-governance [23] is important to ensure mutual-
ity of understanding among academic and industry
stakeholders. Stewardship of various aspects of the pro-
ject may vary during the redesign process, depending on
the stage and level of guidance required.
The potential for cultural disruption at an organisation
level [24] also needs to be considered to ensure that aca-
demic and industry partnerships remain interactive, in-
terrelated and dynamic [19]. At an individual level,
engagement rather than resistance needs to be promoted
to minimise workforce stress arising from the drive to-
wards efficient delivery of healthcare. Parameters around
which stakeholders are fundholders and how resources
will be distributed require transparent negotiation, in-
cluding appropriate documentation of meetings, con-
tracts or variations to proposed plans [25].
Levels of partnership may also vary based on where
in the clinical redesign pathway participants are en-
abled or ready to participate [20]. For example,
academic involvement can ensure timely, structured
development of the diagnostic process and guide the
solutions phase when issues are divulged during map-
ping and diagnosis. The implementation phase needs
to be championed by stakeholders involved in the
process and those most likely to benefit from the out-
comes [26]. The evaluation phase could be managed
by members of the academic institution with input
from the clinical team [26]. Regardless of the level of
partnership is the need to foster rapport development,
recognise each stakeholder’s unique contribution, and
cultivate trust and mutual respect [1]. Without ac-
knowledgement of each stakeholder’s perspective and
expertise, it is likely that the partnership will fail.
Determining roles in redesign
Within the process of clinical redesign, there are several
key roles that need to be established at the outset of the
redesign project. Academic involvement instantly re-
lieves pressure from the healthcare organisations to de-
liver in all these roles. The project steering committee
will generally consist of a mix of clinical and managerial
staff at varying levels, therein creating a potential issue
regarding ownership of the project. The academic is
generally employed by the steering committee to func-
tion as the project lead. This role includes ensuring that
the processes and procedures for clinical redesign are
adhered to within the governance framework of research
ethics and the healthcare organisation. When healthcare
redesign utilises the knowledge and skills of stakeholders
from academic institutions and industry, potential is cre-
ated for collaboration and positive change. However, dif-
ferent levels of partnership may emerge based on the
nature and scope of redesign desired. These stakeholders
or team members will be responsible for initial mapping,
maintaining initiatives and documenting the phases of
the project. Agreement about which stakeholders will be
responsible for administration of the overall project and
how this will be undertaken will need to be clear early in
the project, prior to, or in the very early stages of the
mapping phase. Often, the administration of projects will
be determined by the funding source. If this is the case,
it is the responsibility of the project team to nominate
stakeholders or team members who will be responsible
for ensuring appropriate documentation and milestones
are reported to funding bodies in a timely manner. This
highlights the requirement for time-rich project team
members and ongoing resources, of which healthcare or-
ganisations generally have neither.
It is claimed that, for clinical redesign to be successful, all
stages of the process need to be clearly visible to all involved
[6]. If this process, or any part of the process, is solely under-
taken by academics, clinicians may view the process as im-
posed rhetoric rather than fact [6]. Academics are not
employed to manage a patient case load and their input may
be viewed as unwanted as there may be a perceived discon-
nection of academics to the reality of everyday clinical prac-
tice. This gap between what is viewed as the best practice
within academia and the day-to-day reality of healthcare
practice can be a source of friction. Academics are some-
times viewed by those in clinical practice as overly idealist in
their approach and are only able to view the world from
their ‘ivory towers’ [27]. This is not a new debate, Waring
and Bishop [22] contend healthcare redesign has faced simi-
lar issues between the competing ‘logic’ gap of managers
and healthcare professionals. The ‘logic’ gap may also be
viewed in terms of a competing agenda between the two or-
ganisations. Sahs et al. [21] contends clinicians may mistrust
the academics’ intentions and goals. Clinicians may feel that
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academics do not have the patient at the centre of the re-
design process – rather they are involved as a career devel-
opment opportunity or to seek funding opportunities [21].
Language can also be a barrier to academic input in
healthcare redesign and academics must be aware of the
impact of this when communicating with clinical staff and
other members of the redesign team. If academic staff
present as distant from the clinical practice environment,
then trust and respect will be difficult to develop and
maintain. The partnership must share a common language
as it is important to overcome differing workplace cultures
and values [28]. Academics involved in clinical redesign
must adapt their language to ensure that the ultimate
goals of the redesign are meaningful and relevant to the
intended context.
The main aim of clinical redesign is to improve patient
experience and care; however, clinicians and managers
often have different views on strategies for delivering
these goals. The Partnership model [29] depicts two as-
pects of clinical care – managerial and clinical, which
might also be termed evidence-based care. Both manage-
ment and clinicians can be described as interested in pa-
tients; however, there is suspicion from clinicians that
the intentions of management are at clinicians’ expense
and certainly not for the benefit of patients. From the
management perspective, clinicians may be viewed as
self-interested and, in some cases, unable to understand
the ‘big picture’ of financial pressures and fighting for
their own interests. Roles such as those of medical direc-
tors are intended to bridge management and clinical
hierarchies, with some hybrid roles being highly success-
ful provided that they are not seen to overly support
management and, therefore, not perceived by clinicians
as losing clinical credibility.
Academics can play a very useful role in terms of
bridging the roles and functions of the management
and clinical streams. In terms of sustainability, the two
streams and the way they work together are important.
If management invite the academic institution into a
project, then there may be some mistrust by clinicians
at the outset. University colleagues need to work hard
to assert their independence in the process. Creating
balance between management and clinical agendas is
more likely to be sustainable than if only one stake-
holder group invites the university academics to partici-
pate. The development of balance recognises the needs
of both the streams of practice and university group
members who undertake valuable roles and functions
within redesign projects. The lack of acknowledgement
of either group by stakeholders is related to the notion
of ownership of the project. If management leads the
project, then it is less likely to be owned by clinical
practice, and therefore less likely to be a sustainable
project. For instance, performance data in a project
could be produced by management or the university.
However, the issue here will be that performance data
are about the performance of the clinical team; there-
fore, the development of the criteria for the collection,
the collection itself and the analysis of the data being
carried out by the clinicians is a situation which is
much more likely to embed change in the project and
long after it is supposedly finished given that clinicians
own the process. Of course, assistance by academics
can be offered in terms of literature review work, which
then allows the clinicians to choose the criteria based
on a synthesis of previous studies. Additionally, the de-
velopment of data collection instruments, which make
the process easier and more focused, could be per-
formed by academics to support the process of re-
design. These examples of academic support for the
project rely on ownership by the clinicians, which in
most cases translates into sustainability of the project
outcomes. Once foundation processes of team building
and development of a collaborative approach are
complete, the work of planning the redesign project
can begin [26].
Project deliverables/outcomes
Excluding academic involvement in clinical redesign
projects can lead to various external failings, including
the lack of quality publications and the ultimate failure
to share both the process and results with a wider audi-
ence [30]. Dissemination of successful healthcare re-
design initiatives is imperative to move forward both the
redesign agenda and healthcare systems [31]. Building a
base for translating redesign knowledge into clinical
practice is stronger with input from academics, who
generally have a better knowledge of tools such as ethics
processes, publication avenues and external funding op-
portunities than clinical staff. Having academic involve-
ment in these aspects assists in building a research
culture and developing research networks within the
clinical practice environment [32]. Furthermore, publica-
tion and other dissemination activities, such as confer-
ence presentations, reports and sharing positive results
via social media, are also ways to celebrate achievement
and develop the positive culture required for the longev-
ity and sustainability of the redesign [33]. Caution must
be taken by academics to ensure the dissemination of
any process or results explicitly includes the partner
stakeholders to avoid being seen to take ownership and
credit for the process [34].
Lack of ethical approval contravenes academic integ-
rity and has the potential to expose organisations to liti-
gation [25]. Perceived omission of human rights through
contravention of the ethical approval framework will ter-
minate a project [25, 30]; therefore, it is imperative to
engage the correct mix of stakeholders to ensure ethical
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approval is granted [25]. Appropriate design to ensure
unbiased implementation can minimise poorly designed
studies. For example, Rathmell and Sandberg [30] report
that projects often grow from a desire to effect change;
however, analytical flaws and lack of ethical approval
render the work unpublishable [30]. Avoidance of this
scenario can occur if academic input is sought prior to
the design of any clinical project.
Conclusion
Academic practice partnerships are undoubtedly fruitful.
Too often, questionable clinical practices continue that
remain unchallenged. Clinical practice has many prac-
tical challenges and academics with clinically credible re-
search skills have their place in solving these problems.
Working relationships and ownership of the project
needs to be transparent; however, for sustainability, the
engagement of clinical staff is paramount. For clinical re-
design to become synergistic and successful requires
mutual understanding of both the knowledge and skills
of academics and clinicians.
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